Skip to content

Trial · Interventional

CompletedPhase 4Registry data

Management of Third-stage of Labor After Second Trimester Medical Pregnancy Termination

Short name ANDDROID

NCTNCT02969447 (opens ClinicalTrials.gov in a new tab)Other idCHUBX 2016/20Other id2016-003143-11Other id2016
Open at ClinicalTrials.govAsk about this trial

Overview

Status
Completed
Phase
Phase 4
Enrollment
27 participants (estimated)
Sponsor
University Hospital, Bordeaux · Other
Design
Randomized · Open label (no masking)
Countries
1 country

France

Start
20 Oct 2016
Primary completion
4 Aug 2017
Completion
4 Aug 2017
First posted
21 Nov 2016 (estimated)
Last update posted
12 May 2026
Conditions
Retained Placenta

Timeline

1 trial · 1 completed

  • Completed
  • Ongoing
  • Not yet recruiting
  • Stopped
  • Estimated dates (est.)
  • Results posted
201620172018
  1. Ph 4

    ANDDROID

    NCT02969447

    20 Oct 2016 to 4 Aug 2017

Registry summary

Text and fields below are the sponsor's entries at ClinicalTrials.gov, shown as posted.

Prospective randomized trail which compare 2 regimens for third-stage management after second trimester medical pregnancy termination : 10UI intra venous oxytocin or no additional medication after fetal expulsion. Primary outcome was the incidence of placental retention.

Interventions

  • Administration of 10 units of intra venous oxytocin after fetal expulsionDrug

Arms2

  • Experimental

    Oxytocin administration after fetal expulsion

    Administration of 10 units of intra venous oxytocin after fetal expulsion

  • No intervention

    No additional medication after fetal expulsion

Primary outcomes1

Outcomes the sponsor listed as primary.

  1. Incidence of placental retention

    Time frame · Up to 30 minutes after fetal expulsion

Secondary outcomes(5)

  1. Incidence of partial placental retention

    Time frame · Up to 1 hour after fetal expulsion

  2. Incidence of digital exploration

    Time frame · Up to 1 hour after fetal expulsion

  3. Incidence of blunt curettage

    Time frame · Up to 1 hour after fetal expulsion

  4. Incidence of post-partum hemorrhage

    Time frame · Up to 1 hour after fetal expulsion

  5. Blood loss

    Time frame · Up to 1 hour after fetal expulsion

Posted results

Values are shown as posted at ClinicalTrials.gov, with their units. PepBank has not converted, pooled or compared them.

No results are posted for this trial.

Completed trials do not always post results.

Registry data comes from ClinicalTrials.gov. Study results come from studies, not from the registry. How PepBank works

Studies0

Studies that cite this trial.

No study cites this trial.

Eligibility

Who could join, as posted.

Sex
Female
Age
from 18 Years
Healthy volunteers
Not accepted
Inclusion and exclusion criteria, as posted
Inclusion Criteria: * 18 years old and older * medical pregnancy termination between 14 and 28 weeks gestation * informed consent obtained Exclusion Criteria: * less than 18 years old * refusal to consent * in utero fetal death

PepBank is a research reference. Talk to a doctor before you use any peptide.